Megacap opportunities outside SMID-cap focus
Conviction: 72%
· Horizon: 5Y
· 2026-07-14
Eli Lilly’s ~$1T market cap understates its pipeline and platform build-out
A trillion-dollar valuation can still leave room when obesity, diabetes, and neuroscience franchises are scaling with durable pricing power and a deep late-stage pipeline. Revenue and indication expansion can outpace what the current multiple implies.
| Instrument | Side | Target | Reason |
|---|---|---|---|
| LLY | Long | Scale in metabolic and neuroscience therapies plus a broad development slate supports earnings power above what a $1T cap typically prices in for a single-product story. |
Micron benefits from memory demand tied to AI infrastructure growth
High-bandwidth memory and DRAM/NAND cycles are tightening as hyperscale and edge AI deployments absorb supply. Margins and capex discipline can amplify upside when bit growth reaccelerates.
| Instrument | Side | Target | Reason |
|---|---|---|---|
| MU | Long | AI-driven memory intensity and improving industry supply-demand balance favor leaders with HBM and advanced node exposure. |
Themes
LLY
MU
Megacap opportunities outside SMID-cap focus
2026-07-14
TKR
6481.T
Robotics actuator and bearing components
2026-07-14
GECC
ORLA
HTLD
MEOH
NCNO
JD
BWAY
Earnings Estimate Momentum Across Five Newly Highlighted Stocks
2026-07-14
FXY
The end of structural yen devaluation
2026-07-13
QQQ
TLT
Tactical 10–20% correction with rotation from new-era leaders to the broad market
2026-07-13
TLT
End of the yen devaluation regime
2026-07-13
NVDA
MU
AAOI
Hyperscaler AI capital expenditure surge leaves semiconductor and optical names cheap on pullbacks
2026-07-13
TEM
Tempus AI data and applications revenue scale
2026-07-13
RBC
Robotics actuator and bearing components as the primary BOM leverage in humanoid growth
2026-07-13
URA
SMR
DNN
Uranium sector pullback as a multi-decade entry
2026-07-13
MU
QQQ
Passive flows and benchmark concentration have structurally broken buy-and-hold returns and active stock picking
2026-07-13
ROKU
M&A locks Roku out of momentum investing
2026-07-13
NVGN.MX
Neurorepair value shifts from copyable peptides to mapped, monetizable functional outcomes
2026-07-13
KRE
IWM
Small-cap and cyclical leadership rotation
2026-07-12
MAGS
SMH
Semiconductor complex near-term repair phase
2026-07-12
MU
Semiconductor memory at cyclical profit peak
2026-07-12
SREMF
Early stake in Summit Ridge energy vehicle
2026-07-11
MRVL
DELL
AMD
VRT
Hardware and AI infrastructure leaders lead a narrow high-conviction watchlist
2026-07-11
Bloom Energy short thesis scrutiny
2026-07-11
SREMF
NB.V
Non-Chinese scandium supply chain
2026-07-11
Liquidity outweighs hawkish Fed messaging
2026-07-10
ALB
Lithium equities as a dollar-softening trade
2026-07-10
GLD
Affordability crisis reflects post-2008 centrally managed finance, not market capitalism
2026-07-09
PALI
Palisade Bio director repeat buying
2026-07-09
AVO
Mission Produce insider accumulation cluster
2026-07-09
XYZ
Block Earnings Estimates Move Higher
2026-07-09
DHX
DHI Group Earnings Expectations Strengthen
2026-07-09
COOK
Traeger Earnings Momentum Improves
2026-07-09
SOXX
AI trade cyclical peak
2026-07-08
KWEB
China internet leadership on weak US breadth
2026-07-08
IWM
US small-cap year-to-date leadership
2026-07-08
USO
US–Iran geopolitical escalation
2026-07-08
The content on this page is for informational purposes only and does not constitute financial advice. Stoquate is not a licensed financial advisor. Always conduct your own research and consult a qualified professional before making any investment decisions.